Heritable Forms of Pulmonary Arterial Hypertension

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Seminars in Respiratory and Critical Care Medicine

• Publication date

  2013-09-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0033-1355443PMID 24037626PMCID PMC4102304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics and genomics of pulmonary arterial hypertension.

  2013cited by this paper
• A novel channelopathy in pulmonary arterial hypertension.

  2013cited by this paper
• Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

  2013cited by this paper
• A novel channelopathy in pulmonary arterial hypertension.

  2013cited by this paper
• New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

  2012cited by this paper
• Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension

  2012cited by this paper
• Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation

  2012cited by this paper
• Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution

  2012cited by this paper
• [Pulmonary hypertension].

  2012cited by this paper
• Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

  2012cited by this paper
• Exome sequencing as a tool for Mendelian disease gene discovery

  2011cited by this paper
• A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore

  2011cited by this paper
• Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation.

  2010cited by this paper
• Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

  2010cited by this paper
• The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the ‘endothelium-derived hyperpolarizing factor’

  2010cited by this paper
• The role of caveolin‐1 in cardiovascular regulation

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females

  2009cited by this paper
• Clinical and Translational Implications for the Caveolin Gene Family: Lessons from Mouse Models and Human Genetic Disorders

  2009cited by this paper
• Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.

  2009cited by this paper
• Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.

  2009cited by this paper
• Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension

  2009cited by this paper
• Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele

  2009cited by this paper
• A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation.

  2009cited by this paper
• A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Genetics and genomics of pulmonary arterial hypertension.

  2009cited by this paper
• Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.

  2008cited by this paper
• Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.

  2008cited by this paper
• Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies

  2008cited by this paper
• Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

  2008cited by this paper
• Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice.

  2008cited by this paper
• Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology

  2008cited by this paper
• Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.

  2008cited by this paper
• Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

  2008cited by this paper
• Caveolin-1 regulates BMPRII localization and signaling in vascular smooth muscle cells.

  2008cited by this paper
• Caveolae as organizers of pharmacologically relevant signal transduction molecules.

  2008cited by this paper
• What Patients and Their Relatives Think About Testing for BMPR2

  2008cited by this paper
• BMPR2 mutation and outcome in pulmonary arterial hypertension: clinical relevance to physicians and patients.

  2008cited by this paper
• Synergistic heterozygosity for TGFβ1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension

  2008cited by this paper
• Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.

  2008cited by this paper
• Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance

  2008cited by this paper
• The multiple faces of caveolae

  2007cited by this paper
• Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease.

  2007cited by this paper
• Increased smooth muscle cell expression of caveolin‐1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension

  2007cited by this paper
• Pulmonary Artery Hypertension: Caveolin-1 and eNOS Interrelationship: A New Perspective

  2007cited by this paper
• Function of Kv 1 . 5 channels and genetic variations of KCNA 5 in patients with idiopathic pulmonary arterial hypertension

  2007cited by this paper
• Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.

  2007cited by this paper
• Nitric oxide, caveolae, and vascular pathology

  2007cited by this paper
• Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice

  2007cited by this paper
• Novel Mechanism of Endothelial Nitric Oxide Synthase Activation Mediated by Caveolae Internalization in Endothelial Cells

  2006cited by this paper
• Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease

  2006cited by this paper
• Genetic association of the serotonin transporter in pulmonary arterial hypertension.

  2006cited by this paper
• Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?

  2006cited by this paper
• Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells

  2006cited by this paper
• Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.

  2006cited by this paper
• BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension

  2006cited by this paper
• Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.

  2006cited by this paper
• Caveolins and the regulation of endothelial nitric oxide synthase in the heart.

  2006cited by this paper
• The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro.

  2006cited by this paper
• Different Routes of Bone Morphogenic Protein (BMP) Receptor Endocytosis Influence BMP Signaling

  2006cited by this paper
• An evidence-based approach to the management of pulmonary arterial hypertension.

  2006cited by this paper
• Genes and Pulmonary Arterial Hypertension

  2006cited by this paper
• High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.

  2006cited by this paper
• Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension

  2006cited by this paper
• An evidence-based approach to the management of pulmonary arterial hypertension.

  2006cited by this paper
• Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension

  2006cited by this paper
• Caveolin-1 and regulation of cellular cholesterol homeostasis.

  2006cited by this paper
• Enhanced hypoxic pulmonary vasoconstriction in families of adults or children with idiopathic pulmonary arterial hypertension.

  2005cited by this paper
• Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

  2005cited by this paper
• Repeat instability: mechanisms of dynamic mutations

  2005cited by this paper
• The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis.

  2005cited by this paper
• Pulmonary hypertension.

  2005cited by this paper
• Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.

  2005cited by this paper
• Serotonin transporter gene polymorphism in a cohort of German patients with idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

  2005cited by this paper
• Dynamics and interaction of caveolin-1 isoforms with BMP-receptors

  2005cited by this paper
• Genetics of Pulmonary Arterial Hypertension: Current and Future Implications

  2005cited by this paper
• Idiopathic pulmonary hypertension: what did we learn from genes?

  2005cited by this paper
• Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

  2005cited by this paper
• Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.

  2005cited by this paper
• [Genetics of pulmonary arterial hypertension: recent data and practical applications].

  2005cited by this paper
• Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France.

  2005cited by this paper
• Clinical classification of pulmonary hypertension.

  2004cited by this paper
• Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension

  2004cited by this paper
• BMPR2 mutations found in Japanese patients with familial and sporadic primary pulmonary hypertension

  2004cited by this paper
• Genetic basis of pulmonary arterial hypertension: current understanding and future directions.

  2004cited by this paper
• [Genetics of primary pulmonary hypertension].

  2004cited by this paper
• Role of caveolae and caveolins in health and disease.

  2004cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease

  2004cited by this paper
• Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension

  2004cited by this paper
• Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension

  2003cited by this paper
• Caveolin regulation of endothelial function.

  2003cited by this paper
• Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics

  2003cited by this paper
• Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

  2003cited by this paper
• Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Primary pulmonary hypertension.

  2003cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper

• A Large Animal Model of Heritable Pulmonary Arterial Hypertension Using Gene-edited BMPR2 Sheep

  2026cites this paper
• Case Report: BMPR2-Targeted MinION Sequencing as a Tool for Genetic Analysis in Patients With Pulmonary Arterial Hypertension

  2021cites this paper
• Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants

  2020cites this paper
• Bases genéticas de la hipertension arterial pulmonar

  2020influential citation
• Genetic basis of pulmonary arterial hypertension

  2020influential citation
• O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension

  2019cites this paper
• Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

  2019cites this paper
• Molecular Analysis of BMPR 2 , TBX 4 , and KCNK 3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension

  2019influential citation
• Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site.

  2018cites this paper
• Inherited pulmonary arterial hypertension

  2018cites this paper
• Clinical Presentation with High Penetrance in a Korean Family with Pulmonary Arterial Hypertension Associated with a BMPR2 Intron 3 Splice Site Pathogenic Variant

  2018cites this paper
• Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.

  2016influential citation
• Applying pharmacogenomics in the therapeutics of pulmonary diseases

  2016cites this paper
• Análisis de los genes BMPR2, TBX4 y KCNK3 y correlación genotipo-fenotipo en pacientes y familias españolas con hipertensión arterial pulmonar

  2016cites this paper
• Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

  2016cites this paper
• The role of non-coding RNA in the development of pulmonary arterial hypertension

  2016cites this paper
• Guidelines and Consensus: Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2016cites this paper
• Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives

  2016cites this paper
• A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies

  2015cites this paper
• Mutation in BMPR2 Promoter: A ‘Second Hit’ for Manifestation of Pulmonary Arterial Hypertension?

  2015cites this paper
• Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2015influential citation
• Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.

  2015cites this paper
• Congenital heart defects and pulmonary arterial hypertension

  2014cites this paper
• Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension

  2014cites this paper
• Current clinical management of pulmonary arterial hypertension.

  2014cites this paper
• Identification of a New Intronic BMPR2-Mutation and Early Diagnosis of Heritable Pulmonary Arterial Hypertension in a Large Family with Mean Clinical Follow-Up of 12 Years

  2014cites this paper
• Congenital heart defects and pulmonary arterial hypertension

  2014cites this paper
• KCNK3: new gene target for pulmonary hypertension?

  2014cites this paper
• Riociguat for pulmonary hypertension

  2014cites this paper